Blog Posts by the NCI Director Dr. Norman Sharpless
Dr. Norman Sharpless writes posts for NCI's Cancer Currents Blog that highlight his vision for NCI, meetings with and partnerships in the cancer community, and strategic and scientific initiatives to advance cancer research and care.
Plans for NCI’s Fiscal Year 2019 BudgetPosted: December 18, 2018
NCI Director Dr. Ned Sharpless describes important decisions NCI leaders have recently made with respect to the institute’s fiscal year 2019 budget, including those related to the Cancer Moonshot and early-stage investigators.
Reflections on My First Year as NCI DirectorPosted: November 1, 2018
October 2018 marked Dr. Norman Sharpless’s one-year anniversary as NCI director. He reflects on noteworthy events from the past 12 months and his excitement about leading NCI at such a critical juncture in the history of cancer research.
Hope and Challenge: The NCI Annual Plan and Budget Proposal for Fiscal Year 2020Posted: September 24, 2018
NCI has released its Fiscal Year 2020 Annual Plan and Budget Proposal. The plan represents NCI’s best professional judgement on the optimum funding needed to make the most rapid progress against cancer.
NCI and FDA Address Common Concerns: A Win–Win for Making Progress against CancerPosted: September 17, 2018
NCI Director Dr. Norman Sharpless discusses efforts between NCI and FDA to advance progress against cancer, including initiatives to improve labeling of patient tumor and tissue samples and to address challenges presented by new tobacco products.
Maximizing the Prospects for Progress Against CancerPosted: June 11, 2018
NCI Director Dr. Norman Sharpless highlights some of the important research findings from the 2018 American Society of Clinical Oncology annual meeting and discusses the rapid pace of progress in cancer research.
Advancing Patient Care Through Focused InnovationPosted: April 16, 2018
NCI Director Dr. Norman Sharpless describes the focus areas of opportunity he has identified that, with enhanced attention from NCI, he believes can accelerate progress in cancer research and care.
Forging Military Partnerships to Empower the Cancer Research EnterprisePosted: March 27, 2018
Partnerships and collaborations are an important component of NCI’s success. NCI Director Dr. Norman Sharpless describes three efforts made possible by a memorandum of agreement with three US military institutions: the APOLLO network, NAVIGATE, and BD-STEP.
Retooling NCI MERIT Awards to Support Budding Cancer ResearchersPosted: February 16, 2018
NCI Director Dr. Norman Sharpless discusses how NCI is retooling a grant mechanism, called the MERIT R37 Award, to help early-stage investigators by extending the length of time they can receive funding under their first independent NIH grant.
The Challenging Landscape of Cancer and Aging: Charting a Way ForwardPosted: January 24, 2018
NCI Director Dr. Norman Sharpless discusses research on aging and cancer, including understanding the biology of aging and its relationship to cancer, the treatment of older patients, and ensuring older patients participate in cancer clinical trials.
NCI: Taking Risks to Advance SciencePosted: December 15, 2017
Norman Sharpless, M.D., offers his thoughts on his experience thus far as NCI director and areas, like big data, where NCI can play an important role in advancing science.
Assuming the Role of NCI Director: Working to Accelerate ProgressPosted: November 2, 2017
Norman Sharpless, M.D., discusses his appointment as the director of the National Cancer Institute and his plans for continuing NCI’s long tradition of research excellence and commitment to improving people’s lives.